Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2025)

Arcus Biosciences has reported Prepaid Assets over the past 9 years, most recently at $15.0 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $15.0 million for Q4 2025, down 16.67% from a year ago — trailing twelve months through Dec 2025 was $15.0 million (down 16.67% YoY), and the annual figure for FY2025 was $15.0 million, down 16.67%.
  • Prepaid Assets for Q4 2025 was $15.0 million at Arcus Biosciences, roughly flat from $15.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for RCUS hit a ceiling of $34.0 million in Q4 2023 and a floor of $8.7 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $19.0 million (2022), compared with a mean of $20.8 million.
  • Biggest five-year swings in Prepaid Assets: soared 192.45% in 2021 and later crashed 47.06% in 2024.
  • Arcus Biosciences' Prepaid Assets stood at $16.0 million in 2021, then increased by 18.75% to $19.0 million in 2022, then skyrocketed by 78.95% to $34.0 million in 2023, then crashed by 47.06% to $18.0 million in 2024, then decreased by 16.67% to $15.0 million in 2025.
  • The last three reported values for Prepaid Assets were $15.0 million (Q4 2025), $15.0 million (Q3 2025), and $20.0 million (Q2 2025) per Business Quant data.